FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

703126002: Linaclotide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3007197018 Linaclotide en Synonym Active Entire term case insensitive SNOMED CT core module
3007283017 Linaclotide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Linaclotide Is a Gastrointestinal agent true Inferred relationship Existential restriction modifier
Linaclotide Is a Substance with guanylate cyclase 2C agonist mechanism of action true Inferred relationship Existential restriction modifier
Linaclotide Has disposition Guanylate cyclase 2C agonist true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing linaclotide Has active ingredient True Linaclotide Inferred relationship Existential restriction modifier 1
Product containing precisely linaclotide 145 microgram/1 each conventional release oral capsule (clinical drug) Has active ingredient False Linaclotide Inferred relationship Existential restriction modifier
Product containing precisely linaclotide 290 microgram/1 each conventional release oral capsule (clinical drug) Has active ingredient False Linaclotide Inferred relationship Existential restriction modifier
Linaclotide Has active ingredient True Linaclotide Inferred relationship Existential restriction modifier 1
Product containing precisely linaclotide 145 microgram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance True Linaclotide Inferred relationship Existential restriction modifier 1
Product containing precisely linaclotide 145 microgram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Linaclotide Inferred relationship Existential restriction modifier 1
Product containing precisely linaclotide 290 microgram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance True Linaclotide Inferred relationship Existential restriction modifier 1
Product containing precisely linaclotide 290 microgram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Linaclotide Inferred relationship Existential restriction modifier 1
Product containing linaclotide in oral dose form (medicinal product form) Has active ingredient True Linaclotide Inferred relationship Existential restriction modifier 1
Product containing only linaclotide in oral dose form (medicinal product form) Has active ingredient True Linaclotide Inferred relationship Existential restriction modifier 1
Linaclotide 290microgram capsules Has specific active ingredient True Linaclotide Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) 28 capsule Has specific active ingredient True Linaclotide Inferred relationship Existential restriction modifier
Linaclotide 290microgram capsules 28 capsule Has specific active ingredient True Linaclotide Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has specific active ingredient True Linaclotide Inferred relationship Existential restriction modifier
Linaclotide 290microgram capsules Has active ingredient False Linaclotide Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has active ingredient True Linaclotide Inferred relationship Existential restriction modifier
Linaclotide 290microgram capsules (Ennogen Healthcare Ltd) Has active ingredient False Linaclotide Inferred relationship Existential restriction modifier
Linaclotide 290microgram capsules (Ennogen Healthcare Ltd) Has specific active ingredient False Linaclotide Inferred relationship Existential restriction modifier
Linaclotide 290microgram capsules (Ennogen Healthcare Ltd) 28 capsule Has specific active ingredient False Linaclotide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start